EMEA-001019-PIP01-10-M04

Key facts

Invented name
Lonquex
Active substance
lipegfilgrastim
Therapeutic area
Oncology
Decision number
P/0261/2017
PIP number
EMEA-001019-PIP01-10-M04
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
  • Prevention of chemotherapy-induced febrile neutropenia
  • Treatment of chemotherapy-induced neutropenia
Route(s) of administration
Subcutaneous use
Contact for public enquiries
UAB Sicor Biotech

Tel. +44 (0)20 7540 7117
E-mail: medinfo@tevauk.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating